135 related articles for article (PubMed ID: 2075143)
1. [Gastroenterological complications after bone marrow transplantation].
Ratajczak MZ; Duziak M
Pol Tyg Lek; 1990 Aug 20-27; 45(34-35):716-20. PubMed ID: 2075143
[No Abstract] [Full Text] [Related]
2. [Nephrological complications after bone marrow transplantation].
Ratajczak MZ; Dudziak M
Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):836-40. PubMed ID: 2096379
[No Abstract] [Full Text] [Related]
3. Pulmonary complications following bone marrow transplantation.
Chan CK; Hyland RH; Hutcheon MA
Clin Chest Med; 1990 Jun; 11(2):323-32. PubMed ID: 2189666
[TBL] [Abstract][Full Text] [Related]
4. What is graft versus host disease?
van Bekkum DW
Bone Marrow Transplant; 1991; 7 Suppl 2():110-1. PubMed ID: 1878668
[No Abstract] [Full Text] [Related]
5. Eosinophilia after allogeneic bone marrow transplantation using the busulfan and cyclophosphamide preparative regimen.
Kalaycioglu ME; Bolwell BJ
Bone Marrow Transplant; 1994 Jul; 14(1):113-5. PubMed ID: 7951097
[TBL] [Abstract][Full Text] [Related]
6. Eosinophilia after allogeneic bone marrow transplantation using busulfan and cyclophosphamide conditioning regimen.
Arslan O; Akan H; Koç H; Beksaç M; Ilhan O; Ozcan M; Yalçín S; Gürman G; Konuk N; Uysal A
Bone Marrow Transplant; 1996 Jul; 18(1):261. PubMed ID: 8832034
[No Abstract] [Full Text] [Related]
7. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
[TBL] [Abstract][Full Text] [Related]
8. Successful renal transplantation following prior bone marrow transplantation in pediatric patients.
Thomas SE; Hutchinson RJ; DebRoy M; Magee JC
Pediatr Transplant; 2004 Oct; 8(5):507-12. PubMed ID: 15367289
[TBL] [Abstract][Full Text] [Related]
9. Graft-versus-host disease: effects on long term disease free survival in marrow transplantation for haematological malignancies.
Kapoor N; Copelan EA; Klein J; Tutschka PJ
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():153-5. PubMed ID: 2697430
[No Abstract] [Full Text] [Related]
10. Escalating doses of etoposide with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantation.
Spitzer TR; Cottler-Fox M; Torrisi J; Cahill R; Greenspan A; Lynch M; Deeg HJ
Bone Marrow Transplant; 1989 Sep; 4(5):559-65. PubMed ID: 2676044
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning.
Torjemane L; Ladeb S; Ben Othman T; Abdelkefi A; Lakhal A; Ben Abdeladhim A
Pediatr Blood Cancer; 2006 Apr; 46(4):496-500. PubMed ID: 16333862
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients.
van Besien K; Thall P; Korbling M; Pugh WC; Khouri I; Mehra R; Giralt S; Anderlini P; Amin K; Mirza N; Seong D; Gajewski J; Hester J; Andersson B; Cabanillas F; Champlin R; Przepiorka D
Biol Blood Marrow Transplant; 1997 Aug; 3(3):150-6. PubMed ID: 9310192
[TBL] [Abstract][Full Text] [Related]
13. Orthotopic liver transplantation for acute grade IV hepatic graft-versus-host disease following bone marrow transplantation.
Figuera A; Tomás JF; Otero MJ; Moreno E; García I; Fernández-Rañada JM
Am J Hematol; 1996 May; 52(1):68-9. PubMed ID: 8638625
[No Abstract] [Full Text] [Related]
14. Pediatric bone marrow transplantation.
Chan KW
Pediatr Dent; 1995; 17(4):291-3. PubMed ID: 7567633
[No Abstract] [Full Text] [Related]
15. [Bone marrow transplantation in childhood. II].
Zintl F
Kinderarztl Prax; 1988 Jul; 56(7):321-7. PubMed ID: 3050252
[No Abstract] [Full Text] [Related]
16. Busulfan (Bu) and cyclophosphamide (Cy) for marrow transplantation.
Santos GW
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():236-9. PubMed ID: 2653511
[TBL] [Abstract][Full Text] [Related]
17. Endocrine function after bone marrow transplantation for thalassemia.
Galimberti M; De Sanctis V; Lucarelli G; Polchi P; Angelucci E; Baronciani D; Vullo C; Bagni B
Bone Marrow Transplant; 1991; 7 Suppl 2():74. PubMed ID: 1878729
[No Abstract] [Full Text] [Related]
18. A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic marrow transplantation.
Przepiorka D; Ippoliti C; Giralt S; van Beisen K; Mehra R; Deisseroth AB; Andersson B; Luna M; Cork A; Lee M
Bone Marrow Transplant; 1994 Sep; 14(3):449-53. PubMed ID: 7994271
[TBL] [Abstract][Full Text] [Related]
19. [Allogenic bone marrow transplantation complications. Part II].
Saloua L; Tarek BO; Abderrahman A; Abdeladhim BA
Tunis Med; 2000 Mar; 78(3):152-7. PubMed ID: 11026816
[TBL] [Abstract][Full Text] [Related]
20. Complications in early posttransplantation period in the patients with allogenic and autological bone marrow transplantation.
Lubimova LS; Fainstein FE
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):581-3. PubMed ID: 2480312
[No Abstract] [Full Text] [Related]
[Next] [New Search]
